Jennifer R. Brown

ORCID: 0000-0003-2040-4961

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.518Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Papers

Driven by 62 papers — median percentile 63. Top paper: “Outcomes of COVID-19 in patients with CLL: a multicenter international experience”.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

13.4DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00455-1

N/A

3.3DataRank · unranked

104 citations

Benjamin L. Lampson, Svitlana Tyekucheva, Zixu Wang, Jessica Lowney, Samantha Pazienza +13 more

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Nature Medicine(2023)10.1038/s41591-022-02113-6

N/A

1.7DataRank · unranked

83 citations

Ignaty Leshchiner, Romain Guièze, Connor Johnson, Eugen Tausch, Sameer A. Parikh +49 more

Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0276

N/A

1.5DataRank · unranked

64 citations

Satyen H. Gohil, Caleb A. Lareau, Leif S. Ludwig, Erin M. Parry, Teddy Huang +15 more

Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-19-0058

N/A

0.946DataRank · unranked

30 citations

Anat Biran, Noelia Purroy, Camilla K. Lemvigh, Kendell Clement, Michaela Gruber +22 more

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

American Journal of Hematology(2019)10.1002/ajh.25638

N/A

0.925DataRank · unranked

476 citations

Jennifer R. Brown, Susan O’Brien, Jacqueline C. Barrientos, Paul M. Barr, Nishitha M. Reddy +15 more

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL

Blood Cancer Discovery(2023)10.1158/2643-3230.bcd-22-0156

N/A

0.903DataRank · unranked

29 citations

Meiling Jin, Mike M. Fernandez, Kevyn L. Hart, Aijun Liao, Xinzhou Ge +16 more

Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial

Blood(2024)10.1182/blood.2024024510

N/A

0.874DataRank · unranked

27 citations

Jennifer A. Woyach, Chan Y. Cheah, Catherine C. Coombs, Nirav N. Shah, William G. Wierda +13 more

Nanowire-Mediated Delivery Enables Functional Interrogation of Primary Immune Cells: Application to the Analysis of Chronic Lymphocytic Leukemia

Nano Letters(2012)10.1021/nl3042917

N/A

0.776DataRank · unranked

175 citations

Jellert T. Gaublomme, Lili Wang, Nir Yosef, Nicolas Chevrier, Mette S. Andersen +12 more

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Nature Genetics(2022)10.1038/s41588-022-01140-w

N/A

0.753DataRank · unranked

150 citations

Ziao Lin, Cynthia K. Hahn, Ferran Nadeu, Martí Duran‐Ferrer, Kristen E. Stevenson +34 more

Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

Cancer Research(2021)10.1158/0008-5472.can-21-1273

N/A

0.749DataRank · unranked

22 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect

Science Translational Medicine(2020)10.1126/scitranslmed.abb7661

N/A

0.705DataRank · unranked

24 citations

Christina Ennis, Vinhkhang N. Nguyen, Satyen H. Gohil, Kendell Clement, Sachet A. Shukla +22 more

Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7500

N/A

0.687DataRank · unranked

14 citations

Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little +15 more

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Blood Advances(2020)10.1182/bloodadvances.2020001956

N/A

0.673DataRank · unranked

88 citations

Peter Dreger, Jennifer R. Brown, Oscar Lahoud, Toby A. Eyre, Danielle M. Brander +20 more

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Blood Advances(2022)10.1182/bloodadvances.2022008447

N/A

0.661DataRank · unranked

81 citations

Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen P. Martindale +20 more

Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome

Blood(2022)10.1182/blood.2021011386

N/A

0.650DataRank · unranked

75 citations

Kerry A. Rogers, Svitlana Tyekucheva, Zixu Wang, Samantha Pazienza, Sarah K. Renner +10 more

Germline copy number variation associated with Mendelian inheritance of CLL in two families

Leukemia(2012)10.1038/leu.2012.33

N/A

0.627DataRank · unranked

11 citations

A Vartanov, M Ash, Christine A. Roden, Laura MacConaill, U Hainz +21 more

Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.010

N/A

0.618DataRank · unranked

17 citations

Robert Redd, Erin Jeter, Jeff L. Wong, Kristin M McHugh, Carol Reynolds +21 more

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0068

N/A

0.531DataRank · unranked

17 citations

Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas +19 more

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis

Haematologica(2022)10.3324/haematol.2021.279957

N/A

0.515DataRank · unranked

30 citations

Sara Napoli, Luciano Cascione, Giulio Sartori, Laura Barnabei, Eugenio Gaudio +20 more

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

American Journal of Hematology(2020)10.1002/ajh.26084

N/A

0.510DataRank · unranked

29 citations

Sarah R. Walker, Lisa N. Heppler, Svitlana Tyekucheva, Erik A. Nelson, Josephine L. Klitgaard +15 more

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01441-9

N/A

0.464DataRank · unranked

21 citations

Alec Griffith, Svitlana Tyekucheva, Zixu Wang, Vanessa Rai, Alexander R. Vartanov +14 more

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

Blood(2025)10.1182/blood.2024027009

N/A

0.452DataRank · unranked

6 citations

Bastien Nguyen, Sai Prasad Desikan, Helen Won, Shady I. Tantawy, Samuel McNeely +22 more

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies

Molecular Oncology(2021)10.1002/1878-0261.13153

N/A

0.434DataRank · unranked

17 citations

Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien +6 more

Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia

British Journal of Haematology(2022)10.1111/bjh.18053

N/A

0.416DataRank · unranked

15 citations

Alec Griffith, Zixu Wang, Svitlana Tyekucheva, Vanessa Rai, Stacey M. Fernandes +5 more

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Haematologica(2024)10.3324/haematol.2024.285754

N/A

0.406DataRank · unranked

14 citations

Michael Wang, Lindsey E. Roeker, Krish Patel, Jennifer A. Woyach, William G. Wierda +30 more

Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1221

N/A

0.385DataRank · unranked

12 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0.385DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples

Clinical Epigenetics(2025)10.1186/s13148-025-01959-0

N/A

0.292DataRank · unranked

6 citations

Daniel L. Karl, Kathleen Burke, Megan Callahan, Kerrin Mendler, Pablo Cingolani +13 more

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Blood Cancer Journal(2023)10.1038/s41408-023-00788-9

N/A

0.208DataRank · unranked

3 citations

Stephen P. Martindale, Pui Yan Chiu, Jasneet Kaur Khalsa, Pei-Hsuan Chen, Stacey M. Fernandes +10 more

Investigating the influence of germline ATM variants in chronic lymphocytic leukemia on cancer vulnerability

Haematologica(2024)10.3324/haematol.2024.286031

N/A

0.208DataRank · unranked

3 citations

Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey M. Fernandes +7 more

SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7512

N/A

0.165DataRank · unranked

2 citations

Inhye E. Ahn, Svitlana Tyekucheva, Reid W. Merryman, David C. Fisher, Philippe Armand +7 more

Implementation of a Traceback Testing Program for Ovarian Cancer: Findings from the FACTS Study

Cancers(2025)10.3390/cancers17071154

N/A

0.165DataRank · unranked

2 citations

M. Cabell Jonas, Paula R. Blasi, Adam H. Buchanan, Pim Suwannarat, Kathleen A. Leppig +25 more

Whole Genome Sequencing Identifies Functional Mutations In the Wnt Pathway In CLL

Blood(2010)10.1182/blood.v116.21.693.693

N/A

0.153DataRank · unranked

1 citations

Nathalie Pochet, Kristian Cibulskis, Wandi Zhang, Mike Lawrence, Quinlan L. Sievers +12 more

1.11 Integrative Genomic Analysis Implicates PIK3CA and MYC in Chronic Lymphocytic Leukemia

Clinical Lymphoma Myeloma and Leukemia(2011)10.1016/j.clml.2011.09.012

N/A

0.133DataRank · unranked

1 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.14.488428

N/A

0.104DataRank · unranked

1 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Ishwarya Murali, Stacey M. Fernandes +11 more

Risk Alleles Identified in Genome-Wide Association Studies Are Associated with Expression Quantitative Trait Loci in Chronic Lymphocytic Leukemia.

Blood(2012)10.1182/blood.v120.21.2875.2875

N/A

0.104DataRank · unranked

1 citations

Lillian Werner, Megan Hanna, Ma. Reina Improgo, Nathalie Pochet, Stacey M. Fernandes +8 more

ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.01.522017

N/A

0DataRank · unranked

2 citations

Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas +19 more

Data from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

(2023)10.1158/0008-5472.c.6503108.v1

N/A

0DataRank · unranked

0 citations

Xiaowen Ge, Tao You, Ting Xu, Jinyan Zhang, Gongxiong Wu +7 more

Data from Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

(2023)10.1158/0008-5472.c.6513540.v1

N/A

0DataRank · unranked

0 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6518805.v1

N/A

0DataRank · unranked

0 citations

Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy +9 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718.v1

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Data from Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History

(2023)10.1158/2159-8290.c.6549383.v1

N/A

0DataRank · unranked

0 citations

Satyen H. Gohil, Caleb A. Lareau, Leif S. Ludwig, Erin M. Parry, Teddy Huang +15 more

Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study

Blood(2023)10.1182/blood-2023-186145

N/A

0DataRank · unranked

0 citations

Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Lindsey E. Roeker, Krish Patel +17 more

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.09.033555

N/A

0DataRank · unranked

0 citations

Christina Ennis, Vinhkhang N. Nguyen, Kendell Clement, Satyen H. Gohil, Sachet A. Shukla +20 more

Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22444134.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Clinical Risks for Chronic Lymphocytic Leukemia

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7020

N/A

0DataRank · unranked

5 citations

Jennifer R. Brown

Assaying and Classifying T Cell Function by Cell Morphology

BioMedInformatics(2024)10.3390/biomedinformatics4020063

N/A

0DataRank · unranked

2 citations

Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam, Xin Wang

Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.22444134

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Data from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6520068

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

HemaSphere(2025)10.1002/hem3.70067

N/A

0DataRank · unranked

0 citations

Yue Ren, Svitlana Tyekucheva, Jon Arnason, Adam Boruchov, Caron A. Jacobson +6 more

Data from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6520068.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22444137.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cells

Leukemia(2022)10.1038/s41375-022-01595-0

N/A

0DataRank · unranked

5 citations

Hasan Mahmud, Guru Prasad Maiti, Mariana T. Mendez, Stacey M. Fernandes, Sara K. Vesely +4 more

Multi-Factor Clustering Incorporating Cell Motility Predicts T Cell Expansion Potential

Frontiers in Cell and Developmental Biology(2021)10.3389/fcell.2021.648925

N/A

0DataRank · unranked

5 citations

Shuai Shao, Michelle Kim, Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam +1 more

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

Frontiers in Oncology(2022)10.3389/fonc.2022.897280

N/A

0DataRank · unranked

3 citations

Xiao‐Jie Yan, Wentian Li, Emanuela M. Ghia, Anton W. Langerak, Laura Z. Rassenti +22 more

High-grade heart block associated with ibrutinib therapy

HeartRhythm Case Reports(2021)10.1016/j.hrcr.2021.03.013

N/A

0DataRank · unranked

5 citations

Benjamin L. Lampson, Eric D. Jacobsen, Edwin P. Alyea, Javid J. Moslehi, Jennifer R. Brown +1 more

The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America(2021)10.1016/j.hoc.2021.03.009

N/A

0DataRank · unranked

12 citations

Jennifer R. Brown, Benjamin L. Lampson

Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course

Frontiers in Oncology(2021)10.3389/fonc.2021.640731

N/A

0DataRank · unranked

16 citations

Catherine Tang, Jennifer R. Brown, Siddha Kasar, Stacey M. Fernandes, Monica Colombo +14 more

Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20004

N/A

0DataRank · unranked

0 citations

Sumithra J. Mandrekar, Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander +15 more

Jennifer R. Brown

Indexed papers

Top data-sharing exemplar

Papers